{"product_id":"resorba-synthetic-bone-syringe-6040-mix","title":"RESORBA® Synthetic Bone 60\/40 mix Granules Syringe 0.5-1mm, 0.5cc","description":"  \u003cdiv\u003e\n    \u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0900\/3588\/0226\/files\/Resorba-syntheticBone-Syringe-hero.png?v=1790152126\" style=\"display:block;max-width:100%;justify-self:center;\" alt=\"RESORBA Synthetic Bone Granules in a Syringe 60% HA 40% ß-TCP\"\u003e\n  \u003c\/div\u003e\n\n  \u003c!-- ── HERO ──────────────────────────────────────────────────── --\u003e\n  \u003cdiv class=\"pd-hero\"\u003e\n    \u003cdiv class=\"pd-inner\"\u003e\n      \u003cdiv class=\"pd-hero-tag\"\u003eRESORBA® · MBCP® Synthetic Bone\u003c\/div\u003e\n      \u003ch1 class=\"pd-hero-title\"\u003eSynthetic Bone\u003cbr\u003eGranules in a Syringe\u003c\/h1\u003e\n      \u003cp class=\"pd-hero-sub\"\u003e\n        RESORBA® Synthetic Bone is a fully synthetic bone graft substitute based on Micro-Macroporous Biphasic Calcium\n        Phosphate (MBCP®) technology — a 60% Hydroxyapatite \/ 40% ß-Tricalcium Phosphate composition. Supplied as\n        0.5–1.0 mm granules pre-filled in a ready-to-use syringe, it combines the long-term volume stability of HA with\n        the fast bioactivity of ß-TCP, providing an osteoconductive scaffold with a minimum 70% interconnected porosity\n        for gradual replacement by the patient's own bone.\n      \u003c\/p\u003e\n      \u003cdiv class=\"pd-hero-badges\"\u003e\n        \u003cspan class=\"pd-hero-badge\"\u003e\n          \u003csvg viewbox=\"0 0 16 16\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"1.8\"\u003e\n            \u003ccircle cx=\"8\" cy=\"8\" r=\"6.5\"\u003e\u003c\/circle\u003e\n            \u003cpath d=\"M5 8.5l2 2 4-4\"\u003e\u003c\/path\u003e\n          \u003c\/svg\u003e\n          60% HA \/ 40% ß-TCP Biphasic (MBCP®)\n        \u003c\/span\u003e\n        \u003cspan class=\"pd-hero-badge\"\u003e\n          \u003csvg viewbox=\"0 0 16 16\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"1.8\"\u003e\n            \u003cpath d=\"M3 12l4-4 3 3 4-5\"\u003e\u003c\/path\u003e\n          \u003c\/svg\u003e\n          ≥ 70% Interconnected Porosity\n        \u003c\/span\u003e\n        \u003cspan class=\"pd-hero-badge\"\u003e\n          \u003csvg viewbox=\"0 0 16 16\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"1.8\"\u003e\n            \u003cpath d=\"M8 2v12M2 8h12\"\u003e\u003c\/path\u003e\n          \u003c\/svg\u003e\n          0.5–1.0 mm Granules · Pre-Filled Syringe\n        \u003c\/span\u003e\n      \u003c\/div\u003e\n    \u003c\/div\u003e\n  \u003c\/div\u003e\n\n  \u003c!-- ── CLINICAL INSIGHT ──────────────────────────────────────── --\u003e\n  \u003cdiv class=\"pd-section\"\u003e\n    \u003cdiv class=\"pd-inner\"\u003e\n      \u003cdiv class=\"pd-label\"\u003eClinical Insight\u003c\/div\u003e\n      \u003ch2 class=\"pd-h2\"\u003eWhat clinicians are saying\u003c\/h2\u003e\n      \u003cp class=\"pd-lead\"\u003eReal-world feedback from implant and oral surgeons using RESORBA® Synthetic Bone in their\n        practices.\u003c\/p\u003e\n\n      \u003cdiv class=\"insights-grid\"\u003e\n        \u003cdiv class=\"insight-card\"\u003e\n          \u003cp class=\"insight-quote\"\u003e\n            \"The pre-filled syringe is the detail that won me over for socket and smaller ridge cases — I can deliver\n            the granules exactly where I want them without spilling half the graft on the tray. The 60\/40 ratio holds\n            volume the way I need it to through the healing period, and when I'm grafting outside the ridge contour I'll\n            mix in a little autologous bone. Controlled, predictable, and clean to handle.\"\n          \u003c\/p\u003e\n          \u003cdiv class=\"insight-tag\"\u003eRidge Preservation · Socket Grafting · Handling\u003c\/div\u003e\n        \u003c\/div\u003e\n\n        \u003cdiv class=\"insight-card\"\u003e\n          \u003cp class=\"insight-quote\"\u003e\n            \"What I appreciate about the biphasic composition is how the graft behaves over time — the ß-TCP fraction\n            gets early bone activity going while the hydroxyapatite maintains the scaffold and volume. At re-entry the\n            site looks well integrated with the surrounding bone rather than a block of unresorbed filler. For sinus and\n            GBR work it's become a dependable option when a fully synthetic graft is preferred.\"\n          \u003c\/p\u003e\n          \u003cdiv class=\"insight-tag\"\u003eSinus Lift · GBR · Biphasic Resorption\u003c\/div\u003e\n        \u003c\/div\u003e\n      \u003c\/div\u003e\n    \u003c\/div\u003e\n  \u003c\/div\u003e\n\n  \u003c!-- ── THE BIPHASIC MBCP® PRINCIPLE ──────────────────────────── --\u003e\n  \u003cdiv class=\"pd-section pd-section--muted\"\u003e\n    \u003cdiv class=\"pd-inner\"\u003e\n      \u003cdiv class=\"pd-label\"\u003eHow It Works\u003c\/div\u003e\n      \u003ch2 class=\"pd-h2\"\u003eThe biphasic MBCP® principle\u003c\/h2\u003e\n      \u003cp class=\"pd-lead\"\u003eTwo calcium phosphates, each with a distinct role — engineered to work together for a graft\n        that is gradually replaced by living bone.\u003c\/p\u003e\n\n      \u003cdiv class=\"pillar-grid\"\u003e\n        \u003cdiv class=\"pillar-card\"\u003e\n          \u003cdiv class=\"pillar-icon\"\u003e\n            \u003csvg viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"1.8\"\u003e\n              \u003cpath d=\"M12 3l2.5 5.5 6 .8-4.4 4 1.2 6-5.3-3-5.3 3 1.2-6-4.4-4 6-.8z\"\u003e\u003c\/path\u003e\n            \u003c\/svg\u003e\n          \u003c\/div\u003e\n          \u003cdiv class=\"pillar-title\"\u003eHydroxyapatite — 60%\u003c\/div\u003e\n          \u003cdiv class=\"pillar-desc\"\u003e\n            \u003cp\u003eChemically similar to the mineral phase of natural bone, HA is biocompatible and slow-resorbing. It\n              grants long-term volume stability and a stable scaffold for cell adhesion.\u003c\/p\u003e\n          \u003c\/div\u003e\n        \u003c\/div\u003e\n\n        \u003cdiv class=\"pillar-card\"\u003e\n          \u003cdiv class=\"pillar-icon\"\u003e\n            \u003csvg viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"1.8\"\u003e\n              \u003ccircle cx=\"12\" cy=\"12\" r=\"3\"\u003e\u003c\/circle\u003e\n              \u003cpath d=\"M12 2v3M12 19v3M4.2 4.2l2.1 2.1M17.7 17.7l2.1 2.1M2 12h3M19 12h3M4.2 19.8l2.1-2.1M17.7 6.3l2.1-2.1\"\u003e\u003c\/path\u003e\n            \u003c\/svg\u003e\n          \u003c\/div\u003e\n          \u003cdiv class=\"pillar-title\"\u003eß-Tricalcium Phosphate — 40%\u003c\/div\u003e\n          \u003cdiv class=\"pillar-desc\"\u003e\n            \u003cp\u003eMore soluble and with fast bio-reactivity, the ß-TCP fraction enhances the ingrowth of pluripotent\n              regenerative cells and triggers new bone formation.\u003c\/p\u003e\n          \u003c\/div\u003e\n        \u003c\/div\u003e\n\n        \u003cdiv class=\"pillar-card\"\u003e\n          \u003cdiv class=\"pillar-icon\"\u003e\n            \u003csvg viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"1.8\"\u003e\n              \u003ccircle cx=\"12\" cy=\"12\" r=\"9\"\u003e\u003c\/circle\u003e\n              \u003cpath d=\"M8 12l3 3 5-6\"\u003e\u003c\/path\u003e\n            \u003c\/svg\u003e\n          \u003c\/div\u003e\n          \u003cdiv class=\"pillar-title\"\u003eGradual Replacement\u003c\/div\u003e\n          \u003cdiv class=\"pillar-desc\"\u003e\n            \u003cp\u003eReleased calcium and phosphate ions stimulate osteoid formation by migrating osteoblasts — so the\n              biphasic graft is gradually replaced by the patient's own bone.\u003c\/p\u003e\n          \u003c\/div\u003e\n        \u003c\/div\u003e\n      \u003c\/div\u003e\n    \u003c\/div\u003e\n  \u003c\/div\u003e\n\n  \u003c!-- ── INDICATIONS ───────────────────────────────────────────── --\u003e\n  \u003cdiv class=\"pd-section\"\u003e\n    \u003cdiv class=\"pd-inner\"\u003e\n      \u003cdiv class=\"pd-label\"\u003eIndications\u003c\/div\u003e\n      \u003ch2 class=\"pd-h2\"\u003eWhen to use RESORBA® Synthetic Bone\u003c\/h2\u003e\n      \u003cp class=\"pd-lead\"\u003eA versatile synthetic graft across the full range of oral bone augmentation procedures — used\n        alone, with a barrier membrane, or as an autograft extender.\u003c\/p\u003e\n\n      \u003cdiv class=\"use-grid\"\u003e\n\n        \u003cdiv class=\"use-item\"\u003e\n          \u003cdiv class=\"use-icon\"\u003e\n            \u003csvg viewbox=\"0 0 20 20\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"1.6\"\u003e\n              \u003cpath d=\"M10 3c0 0-5 3-5 8a5 5 0 0010 0c0-5-5-8-5-8z\"\u003e\u003c\/path\u003e\n              \u003cpath d=\"M10 11v3M8 13h4\"\u003e\u003c\/path\u003e\n            \u003c\/svg\u003e\n          \u003c\/div\u003e\n          \u003cdiv class=\"use-text\"\u003e\n\u003cstrong\u003eRidge Preservation \u0026amp; Extraction Socket\u003c\/strong\u003e — Filling extraction\n            sockets to preserve alveolar ridge volume and dimension ahead of implant placement.\u003c\/div\u003e\n        \u003c\/div\u003e\n\n        \u003cdiv class=\"use-item\"\u003e\n          \u003cdiv class=\"use-icon\"\u003e\n            \u003csvg viewbox=\"0 0 20 20\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"1.6\"\u003e\n              \u003cpath d=\"M4 16l4-4 4 4 4-6\"\u003e\u003c\/path\u003e\n              \u003ccircle cx=\"16\" cy=\"5\" r=\"2\"\u003e\u003c\/circle\u003e\n            \u003c\/svg\u003e\n          \u003c\/div\u003e\n          \u003cdiv class=\"use-text\"\u003e\n\u003cstrong\u003eGuided Bone Regeneration (GBR)\u003c\/strong\u003e — Regenerating localised bone defects\n            around implants, typically in combination with a resorbable barrier membrane.\u003c\/div\u003e\n        \u003c\/div\u003e\n\n        \u003cdiv class=\"use-item\"\u003e\n          \u003cdiv class=\"use-icon\"\u003e\n            \u003csvg viewbox=\"0 0 20 20\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"1.6\"\u003e\n              \u003cpath d=\"M3 17l4-8 3 4 2-6 4 10\"\u003e\u003c\/path\u003e\n            \u003c\/svg\u003e\n          \u003c\/div\u003e\n          \u003cdiv class=\"use-text\"\u003e\n\u003cstrong\u003eSinus-Lift Augmentation\u003c\/strong\u003e — Grafting the maxillary sinus floor to gain\n            vertical bone height for posterior implant placement.\u003c\/div\u003e\n        \u003c\/div\u003e\n\n        \u003cdiv class=\"use-item\"\u003e\n          \u003cdiv class=\"use-icon\"\u003e\n            \u003csvg viewbox=\"0 0 20 20\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"1.6\"\u003e\n              \u003crect x=\"3\" y=\"6\" width=\"14\" height=\"9\" rx=\"2\"\u003e\u003c\/rect\u003e\n              \u003cpath d=\"M7 6V4m6 2V4M3 10h14\"\u003e\u003c\/path\u003e\n            \u003c\/svg\u003e\n          \u003c\/div\u003e\n          \u003cdiv class=\"use-text\"\u003e\n\u003cstrong\u003eRidge Augmentation \u0026amp; Ridge-Split\u003c\/strong\u003e — Horizontal and vertical\n            alveolar ridge augmentation, including ridge-split procedures.\u003c\/div\u003e\n        \u003c\/div\u003e\n\n        \u003cdiv class=\"use-item\"\u003e\n          \u003cdiv class=\"use-icon\"\u003e\n            \u003csvg viewbox=\"0 0 20 20\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"1.6\"\u003e\n              \u003cpath d=\"M10 4a6 6 0 100 12A6 6 0 0010 4zM10 4v2M10 14v2M4 10H2M18 10h-2\"\u003e\u003c\/path\u003e\n            \u003c\/svg\u003e\n          \u003c\/div\u003e\n          \u003cdiv class=\"use-text\"\u003e\n\u003cstrong\u003ePeriodontal \u0026amp; Intrabony Defects\u003c\/strong\u003e — Filling periodontal\n            intra-osseous pockets, furcations, and intrabony defects.\u003c\/div\u003e\n        \u003c\/div\u003e\n\n        \u003cdiv class=\"use-item\"\u003e\n          \u003cdiv class=\"use-icon\"\u003e\n            \u003csvg viewbox=\"0 0 20 20\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"1.6\"\u003e\n              \u003cpath d=\"M5 15l3-6 2 3 2-5 3 8\"\u003e\u003c\/path\u003e\n              \u003cpath d=\"M3 17h14\"\u003e\u003c\/path\u003e\n            \u003c\/svg\u003e\n          \u003c\/div\u003e\n          \u003cdiv class=\"use-text\"\u003e\n\u003cstrong\u003eAutograft Extender \u0026amp; Defect Stabilisation\u003c\/strong\u003e — Extending autologous\n            bone volume, stabilising bone defects, and filling cystic cavities.\u003c\/div\u003e\n        \u003c\/div\u003e\n\n      \u003c\/div\u003e\n    \u003c\/div\u003e\n  \u003c\/div\u003e\n\n  \u003c!-- ── SCIENTIFIC EVIDENCE ───────────────────────────────────── --\u003e\n  \u003cdiv class=\"pd-section pd-section--muted\"\u003e\n    \u003cdiv class=\"pd-inner\"\u003e\n      \u003cdiv class=\"pd-label\"\u003eScientific Evidence\u003c\/div\u003e\n      \u003ch2 class=\"pd-h2\"\u003eStructure, healing \u0026amp; clinical track record\u003c\/h2\u003e\n      \u003cp class=\"pd-lead\"\u003eMicro-macroporous architecture and histological findings that show gradual graft replacement\n        by vital bone, supported by a long clinical record.\u003c\/p\u003e\n\n      \u003c!-- Evidence 1: Structure --\u003e\n      \u003cdiv class=\"evidence-section\"\u003e\n        \u003cp class=\"evidence-title\"\u003e① Micro-macroporous structure for maximum permeability\u003c\/p\u003e\n\n        \u003cdiv class=\"evidence-row\"\u003e\n          \u003cdiv class=\"evidence-img-wrap\"\u003e\n            \u003cdiv\u003e\n              \u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0900\/3588\/0226\/files\/Resorba-syntheticBone-Syringe_Feature_1.png?v=1790152091\" alt=\"Scanning electron microscopy comparison of RESORBA Synthetic Bone porosity and human cancellous bone\"\u003e\n            \u003c\/div\u003e\n            \u003cp class=\"evidence-sub\"\u003eRESORBA® Synthetic Bone vs. Human Bone (SEM)\u003c\/p\u003e\n\n          \u003c\/div\u003e\n          \u003cdiv class=\"evidence-img-wrap\"\u003e\n            \u003cdiv\u003e\n              \u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0900\/3588\/0226\/files\/Resorba-syntheticBone-Syringe_Feature_2.png?v=1790152092\" alt=\"Scanning electron microscopy of the interconnected macropore network of RESORBA Synthetic Bone\" style=\"border-radius: 12px;\"\u003e\n            \u003c\/div\u003e\n            \u003cp class=\"evidence-sub\"\u003eInterconnected Macropores (SEM)\u003c\/p\u003e\n          \u003c\/div\u003e\n        \u003c\/div\u003e\n\n        \u003cul class=\"evidence-points\"\u003e\n          \u003cli\u003eMinimum 70% global porosity — comparable to cancellous bone, colonised by the body's own cells\u003c\/li\u003e\n          \u003cli\u003eInterconnected macropores promote biological infiltration and cellular colonisation by osteoblasts and\n            osteoclasts\u003c\/li\u003e\n          \u003cli\u003eMicropores — the intercrystalline spaces where dissolution and recrystallisation occur — support\n            resorption and remodelling\u003c\/li\u003e\n          \u003cli\u003eHigh specific surface area (SSA) for maximum permeability\u003c\/li\u003e\n        \u003c\/ul\u003e\n      \u003c\/div\u003e\n\n      \u003c!-- Evidence 2: Histology --\u003e\n      \u003cdiv class=\"evidence-section\"\u003e\n        \u003cp class=\"evidence-title\"\u003e② New bone formation \u0026amp; gradual replacement\u003c\/p\u003e\n\n        \u003cdiv class=\"evidence-row\"\u003e\n          \u003cdiv class=\"evidence-img-wrap\"\u003e\n            \u003cdiv\u003e\n              \u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0900\/3588\/0226\/files\/Resorba-syntheticBone-Syringe_Feature_3.png?v=1790152091\" style=\"border-radius: 12px;\" alt=\"Histological section at 6 months showing MBCP particles embedded in newly formed bone\"\u003e\n            \u003c\/div\u003e\n            \u003cp class=\"evidence-sub\"\u003e6 months post-op — sinus augmentation (×100)\u003c\/p\u003e\n\n          \u003c\/div\u003e\n          \u003cdiv class=\"evidence-img-wrap\"\u003e\n            \u003cdiv\u003e\n              \u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0900\/3588\/0226\/files\/Resorba-syntheticBone-Syringe_Feature_4.png?v=1790152092\" style=\"border-radius: 12px;\" alt=\"Histological section at 10 months showing grafted material in close contact with vital bone and osteocytes\"\u003e\n            \u003c\/div\u003e\n            \u003cp class=\"evidence-sub\"\u003e10 months post-op — sinus augmentation (×400)\u003c\/p\u003e\n\n          \u003c\/div\u003e\n        \u003c\/div\u003e\n\n        \u003cul class=\"evidence-points\"\u003e\n          \u003cli\u003eAt 6 months, MBCP® particles are embedded in newly formed bone, with marrow space filled by loose\n            connective tissue and abundant blood vessels\u003c\/li\u003e\n          \u003cli\u003eAt 10 months, grafted material and vital bone are in close contact, with visible osteocytes and a clear\n            reversal line in the newly formed bone\u003c\/li\u003e\n          \u003cli\u003eOver the healing period, new bone increases as the graft gradually resorbs — a balance of resorption and\n            bone ingrowth\u003c\/li\u003e\n        \u003c\/ul\u003e\n      \u003c\/div\u003e\n\n      \u003c!-- Evidence 3: Clinical track record --\u003e\n      \u003cdiv class=\"evidence-section\"\u003e\n        \u003cp class=\"evidence-title\"\u003e③ A proven clinical track record\u003c\/p\u003e\n\n        \u003cul class=\"evidence-points\"\u003e\n          \u003cli\u003eHuman sinus-lift biopsies of the same MBCP® 60\/40, 0.5–1.0 mm granules: micro-CT showed roughly 53% of\n            the granules resorbed and about 22% newly formed bone intimately associated with the granules within the\n            first 6 months, with bone ingrowth sufficient to support dental implants at 6–8 months (Mailhac \u0026amp;\n            Daculsi, 2008)\u003c\/li\u003e\n          \u003cli\u003eHuman maxillary sinus augmentation: MBCP® performed predictably as a sinus-floor grafting material —\n            alone or combined with other grafts — in the posterior maxilla (Lee et al., 2008)\u003c\/li\u003e\n          \u003cli\u003eBacked by more than 30 years of clinical experience and over 1 million units manufactured\u003c\/li\u003e\n        \u003c\/ul\u003e\n      \u003c\/div\u003e\n\n    \u003c\/div\u003e\n  \u003c\/div\u003e\n\n  \u003c!-- ── CLINICAL CASES ────────────────────────────────────────── --\u003e\n  \u003cdiv class=\"pd-section\"\u003e\n    \u003cdiv class=\"pd-inner\"\u003e\n      \u003cdiv class=\"pd-label\"\u003eClinical Case\u003c\/div\u003e\n      \u003ch2 class=\"pd-h2\"\u003eReal-world clinical outcome\u003c\/h2\u003e\n      \u003cp class=\"pd-lead\"\u003eCase with kind permission of Juraj Brozović (DMD, PhD, Asst. Professor, Specialist in Oral\n        Surgery) — demonstrating RESORBA® Synthetic Bone 0.5–1.0 mm granules in an augmentation procedure.\u003c\/p\u003e\n\n      \u003c!-- Case 1: Fenestration (granules — this product format) --\u003e\n      \u003cdiv class=\"case-block\"\u003e\n        \u003ch4 class=\"case-indication\"\u003eFenestration Management after Apicectomy\u003c\/h4\u003e\n        \u003cp class=\"case-sub\"\u003eBone loss following apicectomy, grafted with RESORBA® Synthetic Bone (0.5–1.0 mm granules)\n          — stable healing at 6-month follow-up\u003c\/p\u003e\n        \u003cdiv class=\"case-gallery\"\u003e\n          \u003cdiv class=\"case-img-wrap\"\u003e\n            \u003cdiv class=\"case-step\"\u003e\n              \u003cdiv class=\"case-step-num\"\u003e1\u003c\/div\u003e\n              \u003cdiv\u003e\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0900\/3588\/0226\/files\/Resorba-syntheticBone-Syringe-Case_1.png?v=1790152091\" alt=\"Bone loss following apicectomy — defect cavity\"\u003e\u003c\/div\u003e\n            \u003c\/div\u003e\n            \u003cp class=\"case-caption\"\u003eVisible bone loss after apicectomy\u003c\/p\u003e\n          \u003c\/div\u003e\n          \u003cdiv class=\"case-img-wrap\"\u003e\n            \u003cdiv class=\"case-step\"\u003e\n              \u003cdiv class=\"case-step-num\"\u003e2\u003c\/div\u003e\n              \u003cdiv\u003e\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0900\/3588\/0226\/files\/Resorba-syntheticBone-Syringe-Case_2.png?v=1790152092\" alt=\"RESORBA Synthetic Bone 0.5 to 1.0 mm granules inserted into the defect\"\u003e\u003c\/div\u003e\n            \u003c\/div\u003e\n            \u003cp class=\"case-caption\"\u003eGranules (0.5–1.0 mm) inserted into the defect\u003c\/p\u003e\n          \u003c\/div\u003e\n          \u003cdiv class=\"case-img-wrap\"\u003e\n            \u003cdiv class=\"case-step\"\u003e\n              \u003cdiv class=\"case-step-num\"\u003e3\u003c\/div\u003e\n              \u003cdiv\u003e\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0900\/3588\/0226\/files\/Resorba-syntheticBone-Syringe-Case_3.png?v=1790152091\" alt=\"Defect covered with a resorbable collagen membrane\"\u003e\u003c\/div\u003e\n            \u003c\/div\u003e\n            \u003cp class=\"case-caption\"\u003eCoverage with a resorbable collagen membrane\u003c\/p\u003e\n          \u003c\/div\u003e\n          \u003cdiv class=\"case-img-wrap\"\u003e\n            \u003cdiv class=\"case-step\"\u003e\n              \u003cdiv class=\"case-step-num\"\u003e4\u003c\/div\u003e\n              \u003cdiv\u003e\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0900\/3588\/0226\/files\/Resorba-syntheticBone-Syringe-Case_4.png?v=1790152091\" alt=\"Post-operative CT scan at 6-month follow-up\"\u003e\u003c\/div\u003e\n            \u003c\/div\u003e\n            \u003cp class=\"case-caption\"\u003ePost-op CT at 6-month follow-up\u003c\/p\u003e\n          \u003c\/div\u003e\n        \u003c\/div\u003e\n      \u003c\/div\u003e\n\n    \u003c\/div\u003e\n  \u003c\/div\u003e\n\n  \u003c!-- ── FORMAT \u0026 REFERENCE ────────────────────────────────────── --\u003e\n  \u003cdiv class=\"pd-section pd-section--muted\"\u003e\n    \u003cdiv class=\"pd-inner\"\u003e\n      \u003cdiv class=\"pd-label\"\u003eFormat\u003c\/div\u003e\n      \u003ch2 class=\"pd-h2\"\u003eThis product\u003c\/h2\u003e\n      \u003cp class=\"pd-lead\"\u003eRESORBA® Synthetic Bone, 60% HA \/ 40% ß-TCP mix, supplied as granules in a ready-to-use\n        syringe.\u003c\/p\u003e\n      \u003cdiv style=\"margin-top:30px;border-radius:12px;overflow:hidden;line-height:0;\"\u003e\n        \u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0900\/3588\/0226\/files\/Resorba-syntheticBone-Syringe-pack.png?v=1790152406\" style=\"display:block;width:100%;max-width:100%;\"\u003e\n      \u003c\/div\u003e\n      \u003cdiv class=\"kit-table-wrap\"\u003e\n        \u003ctable class=\"kit-table\"\u003e\n          \u003cthead\u003e\n            \u003ctr\u003e\n              \u003cth\u003eComposition\u003c\/th\u003e\n              \u003cth\u003eParticle Size\u003c\/th\u003e\n              \u003cth\u003eContent \/ Box\u003c\/th\u003e\n            \u003c\/tr\u003e\n          \u003c\/thead\u003e\n          \u003ctbody\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e60% HA \/ 40% ß-TCP (MBCP®)\u003c\/td\u003e\n              \u003ctd\u003e0.5 – 1.0 mm\u003c\/td\u003e\n              \u003ctd\u003e1 syringe, 0.5 cc\u003c\/td\u003e\n            \u003c\/tr\u003e\n          \u003c\/tbody\u003e\n        \u003c\/table\u003e\n      \u003c\/div\u003e\n    \u003c\/div\u003e\n  \u003c\/div\u003e\n\n  \u003c!-- ── SPECIFICATIONS ────────────────────────────────────────── --\u003e\n  \u003cdiv class=\"pd-section\"\u003e\n    \u003cdiv class=\"pd-inner\"\u003e\n      \u003cdiv class=\"pd-label\"\u003eSpecifications\u003c\/div\u003e\n      \u003ch2 class=\"pd-h2\"\u003eTechnical specifications\u003c\/h2\u003e\n\n      \u003ctable class=\"spec-table\"\u003e\n        \u003ctr\u003e\n          \u003ctd\u003eDevice type\u003c\/td\u003e\n          \u003ctd\u003eResorbable synthetic bone graft substitute (bone void filler)\u003c\/td\u003e\n        \u003c\/tr\u003e\n        \u003ctr\u003e\n          \u003ctd\u003eTechnology\u003c\/td\u003e\n          \u003ctd\u003eMicro-Macroporous Biphasic Calcium Phosphate (MBCP®)\u003c\/td\u003e\n        \u003c\/tr\u003e\n        \u003ctr\u003e\n          \u003ctd\u003eComposition\u003c\/td\u003e\n          \u003ctd\u003e60% Hydroxyapatite (HA) \/ 40% ß-Tricalcium Phosphate (ß-TCP)\u003c\/td\u003e\n        \u003c\/tr\u003e\n        \u003ctr\u003e\n          \u003ctd\u003eFormat\u003c\/td\u003e\n          \u003ctd\u003eGranules pre-filled in a ready-to-use syringe\u003c\/td\u003e\n        \u003c\/tr\u003e\n        \u003ctr\u003e\n          \u003ctd\u003eGlobal porosity\u003c\/td\u003e\n          \u003ctd\u003eMinimum 70% — interconnected macro- and micropores\u003c\/td\u003e\n        \u003c\/tr\u003e\n        \u003ctr\u003e\n          \u003ctd\u003eStructure\u003c\/td\u003e\n          \u003ctd\u003eSimilar to cancellous bone\u003c\/td\u003e\n        \u003c\/tr\u003e\n        \u003ctr\u003e\n          \u003ctd\u003eResorption\u003c\/td\u003e\n          \u003ctd\u003eGradual; total resorption time varies with defect size, location, surgical protocol, and patient health\n            status\u003c\/td\u003e\n        \u003c\/tr\u003e\n        \u003ctr\u003e\n          \u003ctd\u003eShelf life\u003c\/td\u003e\n          \u003ctd\u003e5 years\u003c\/td\u003e\n        \u003c\/tr\u003e\n        \u003ctr\u003e\n          \u003ctd\u003eMedical device class\u003c\/td\u003e\n          \u003ctd\u003eClass III (CE — Notified body TÜV SÜD Product Service GmbH, n° 0123)\u003c\/td\u003e\n        \u003c\/tr\u003e\n        \u003ctr\u003e\n          \u003ctd\u003eBrand\u003c\/td\u003e\n          \u003ctd\u003eRESORBA® (Advanced Medical Solutions)\u003c\/td\u003e\n        \u003c\/tr\u003e\n        \u003ctr\u003e\n          \u003ctd\u003eManufacturer\u003c\/td\u003e\n          \u003ctd\u003eBiomatlante SA — Vigneux de Bretagne, France\u003c\/td\u003e\n        \u003c\/tr\u003e\n        \u003ctr\u003e\n          \u003ctd\u003eOrigin\u003c\/td\u003e\n          \u003ctd\u003eMade in France\u003c\/td\u003e\n        \u003c\/tr\u003e\n      \u003c\/table\u003e\n    \u003c\/div\u003e\n  \u003c\/div\u003e\n\n  \u003c!-- ── CLINICAL TIPS ─────────────────────────────────────────── --\u003e\n  \u003cdiv class=\"pd-section\"\u003e\n    \u003cdiv class=\"pd-inner\"\u003e\n      \u003cdiv class=\"pd-label\"\u003eClinical Tips\u003c\/div\u003e\n      \u003ch2 class=\"pd-h2\"\u003eGetting the most from RESORBA® Synthetic Bone\u003c\/h2\u003e\n      \u003cp class=\"pd-lead\"\u003ePractical guidance for predictable augmentation outcomes.\u003c\/p\u003e\n\n      \u003cdiv class=\"tips-list\"\u003e\n\n        \u003cdiv class=\"tip-item\"\u003e\n          \u003cdiv class=\"tip-num\"\u003e1\u003c\/div\u003e\n          \u003cdiv class=\"tip-body\"\u003e\n\u003cstrong\u003eThe 60\/40 ratio is the all-round choice for oral augmentation.\u003c\/strong\u003e The\n            slow-resorbing hydroxyapatite grants long-term volume stability of the graft, while the more soluble ß-TCP\n            triggers new bone formation. It can be used for all bone augmentations in the oral cavity.\u003c\/div\u003e\n        \u003c\/div\u003e\n\n        \u003cdiv class=\"tip-item\"\u003e\n          \u003cdiv class=\"tip-num\"\u003e2\u003c\/div\u003e\n          \u003cdiv class=\"tip-body\"\u003e\n\u003cstrong\u003eMix with autologous bone for larger defects and grafting outside the ridge\n              contour.\u003c\/strong\u003e Where enhanced neovascularisation and increased early bone formation are needed, the\n            addition of autogenous bone chips brings osteoinductive and osteogenic properties to the osteoconductive\n            scaffold. Mixing with autologous bone is recommended for bigger defects.\u003c\/div\u003e\n        \u003c\/div\u003e\n\n        \u003cdiv class=\"tip-item\"\u003e\n          \u003cdiv class=\"tip-num\"\u003e3\u003c\/div\u003e\n          \u003cdiv class=\"tip-body\"\u003e\n\u003cstrong\u003eUse the syringe for controlled delivery into sockets and confined\n              defects.\u003c\/strong\u003e The pre-filled granules can be delivered directly to the site with minimal waste. Where\n            a barrier is indicated (e.g. GBR), cover the graft with a resorbable collagen membrane and aim for\n            tension-free primary closure.\u003c\/div\u003e\n        \u003c\/div\u003e\n\n        \u003cdiv class=\"tip-item\"\u003e\n          \u003cdiv class=\"tip-num\"\u003e4\u003c\/div\u003e\n          \u003cdiv class=\"tip-body\"\u003e\n\u003cstrong\u003ePlan resorption on a case-by-case basis.\u003c\/strong\u003e Total resorption time depends\n            on the size and location of the bone defect, the surgical protocol, and the patient's health status — it is\n            not a fixed timeline. Base re-entry timing on individual assessment.\u003c\/div\u003e\n        \u003c\/div\u003e\n\n      \u003c\/div\u003e\n\n      \u003cdiv class=\"tip-warn\"\u003e\n        \u003cstrong\u003e⚠ Clinical Notice:\u003c\/strong\u003e RESORBA® Synthetic Bone is a Class III bone void filler intended for use by\n        trained dental and oral surgeons. Read the Instructions for Use and labels carefully before use. Do not use if\n        the packaging is damaged or sterility is compromised. Refer to the Instructions for Use for full indications,\n        contraindications, and handling guidelines.\n      \u003c\/div\u003e\n    \u003c\/div\u003e\n  \u003c\/div\u003e","brand":"RESORBA","offers":[{"title":"Default Title","offer_id":52457418883362,"sku":"SB0401GS50","price":260.0,"currency_code":"AUD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0900\/3588\/0226\/files\/syntheticbone-1.png?v=1788937691","url":"https:\/\/xdentalsupplies.com.au\/products\/resorba-synthetic-bone-syringe-6040-mix","provider":"X Dental Supplies","version":"1.0","type":"link"}